# COSENTYX
> **BLA761349** · Biologics License Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2023-10-06
## Drug
- **FDA Application Number:** BLA761349
- **Application type:** Biologics License Application
- **Brand name:** COSENTYX
- **Generic name:** SECUKINUMAB
- **Active ingredients:** SECUKINUMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS PHARMS CORP
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2023-10-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761349)
---
*MORVS · CC0 1.0*